These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20370621)

  • 1. Prospects for the development and use of gram-negative bacterial virulence protein secretion inhibitors for prophylaxis and treatment of infectious diseases.
    Felise HB; Miller SI
    Crit Rev Immunol; 2010; 30(1):69-77. PubMed ID: 20370621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inhibitor of gram-negative bacterial virulence protein secretion.
    Felise HB; Nguyen HV; Pfuetzner RA; Barry KC; Jackson SR; Blanc MP; Bronstein PA; Kline T; Miller SI
    Cell Host Microbe; 2008 Oct; 4(4):325-36. PubMed ID: 18854237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.
    Duncan MC; Linington RG; Auerbuch V
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5433-41. PubMed ID: 22850518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotransporter and two-partner secretion: delivery of large-size virulence factors by gram-negative bacterial pathogens.
    Newman CL; Stathopoulos C
    Crit Rev Microbiol; 2004; 30(4):275-86. PubMed ID: 15646401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disarming the invader.
    Young GM
    Chem Biol; 2003 Mar; 10(3):204-5. PubMed ID: 12670533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of bacterial glycoproteins.
    Fulton KM; Smith JC; Twine SM
    Expert Rev Proteomics; 2016; 13(4):345-53. PubMed ID: 26971465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistant gram-negative bacilli: A neglected healthcare crisis?
    Lautenbach E; Polk RE
    Am J Health Syst Pharm; 2007 Dec; 64(23 Suppl 14):S3-21; quiz S22-4. PubMed ID: 18029939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting bacterial secretion systems: benefits of disarmament in the microcosm.
    Baron C; Coombes B
    Infect Disord Drug Targets; 2007 Mar; 7(1):19-27. PubMed ID: 17346208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II secretion: a protein secretion system for all seasons.
    Cianciotto NP
    Trends Microbiol; 2005 Dec; 13(12):581-8. PubMed ID: 16216510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small protein-mediated quorum sensing in a gram-negative bacterium: novel targets for control of infectious disease.
    Ronald PC
    Discov Med; 2011 Dec; 12(67):461-70. PubMed ID: 22204763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural biology of bacterial secretion systems in gram-negative pathogens--potential for new drug targets.
    Durand E; Verger D; Rêgo AT; Chandran V; Meng G; Fronzes R; Waksman G
    Infect Disord Drug Targets; 2009 Nov; 9(5):518-47. PubMed ID: 19594425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence factors of gram-negative bacteria in sepsis with a focus on Neisseria meningitidis.
    Livorsi DJ; Stenehjem E; Stephens DS
    Contrib Microbiol; 2011; 17():31-47. PubMed ID: 21659746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing order for type III secretion substrates--a hierarchical process.
    Thomas NA; Brett Finlay B
    Trends Microbiol; 2003 Aug; 11(8):398-403. PubMed ID: 12915098
    [No Abstract]   [Full Text] [Related]  

  • 15. Type III secretion systems and pathogenicity islands.
    Winstanley C; Hart CA
    J Med Microbiol; 2001 Feb; 50(2):116-126. PubMed ID: 11211218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Dsb proteins of Gram-negative bacteria in the process of pathogenesis.
    Łasica AM; Jagusztyn-Krynicka EK
    FEMS Microbiol Rev; 2007 Sep; 31(5):626-36. PubMed ID: 17696887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-negative bacterial protein secretion.
    Kerr JR
    J Infect; 2000 Mar; 40(2):121-6. PubMed ID: 10841085
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiresistant Gram-negative infections: a global perspective.
    Ho J; Tambyah PA; Paterson DL
    Curr Opin Infect Dis; 2010 Dec; 23(6):546-53. PubMed ID: 20802331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting effectors: the molecular recognition of Type III secreted proteins.
    Arnold R; Jehl A; Rattei T
    Microbes Infect; 2010 May; 12(5):346-58. PubMed ID: 20178857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure and function of the type III secretion system in pathogenic bacteria].
    Kuwae A; Abe A
    Tanpakushitsu Kakusan Koso; 2005 Jan; 50(1):20-8. PubMed ID: 15651413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.